Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

FS-3.6 Data Details

Expand All

FS-3.6 Prevent an increase in the proportion of Campylobacter jejuni isolates from humans that are resistant to erythromycin

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
National Antimicrobial Resistance Monitoring System for Enteric Bacteria
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
percent
Baseline (Year): 
1.6 (2006–08)
Target: 
1.6
Target-Setting Method: 
Maintain the baseline value.
Target-Setting Method Justification: 
Antimicrobial use in humans and food animals provides selective pressure that favors resistant bacteria. Preventing an increase in resistance to erythromycin is vital to preserving the efficacy of this agent. The target represents part of an effort to address increasing resistance to antimicrobial drugs.
Numerator: 

Number of Campylobacter jejuni isolates that are resistant to erythromycin

Denominator: 

Number of Campylobacter jejuni isolates tested for resistance to erythromycin

Comparable Healthy People 2010 Objective: 
Not applicable
Data Collection Frequency: 
Annual
Methodology Notes: 

    The primary objectives of NARMS are to:

    1. Monitor trends in antimicrobial resistance among foodborne bacteria from humans, retail meats, and animals
    2. Disseminate timely information on antimicrobial resistance to promote interventions that reduce resistance among foodborne bacteria
    3. Conduct research to better understand the emergence, persistence, and spread of antimicrobial resistance
    4. Assist the FDA in making decisions related to the approval of safe and effective antimicrobial drugs for animals

    In 1997, surveillance for Campylobacter in NARMS began in sites participating in the Foodborne Disease Active Surveillance Network (FoodNet). There were 5 participating sites in 1997. Since 2003 10 FoodNet sites have been participating: California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New York, New Mexico, Oregon, and Tennessee. The 10 FoodNet sites represent about 49 million or 15% of the US population (US Census Bureau, 2015). Participating sites forward a representative sample of Campylobacter isolates received at their public health laboratories to NARMS at CDC for susceptibility testing. Susceptibility testing involves determination of minimum inhibitory for antimicrobial agentsincluding: azithromycin, ciprofloxacin, clindamycin, erythromycin, florfenicol, gentamicin, nalidixic acid, telithromycin, and tetracycline.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
Due to a change in methodology for data presentation, the original baseline was revised from 2.0 (2006-08) to 1.6 (2006-08). The target was adjusted from 2.0 to 1.6 to reflect the revised baseline using the original target-setting method.

References

Additional resources about the objective

  1. National Antimicrobial Resistance Monitoring System

  2. National Antimicrobial Resistance Monitoring System for Enteric Bacteria